Filing Details

Accession Number:
0001127602-13-026235
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-29 16:41:52
Reporting Period:
2013-08-28
Filing Date:
2013-08-29
Accepted Time:
2013-08-29 16:41:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1014739 Bioscrip Inc. BIOS Retail-Drug Stores And Proprietary Stores (5912) 050489664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1519545 Patricia Bogusz C/O Bioscrip, Inc.
100 Clearbrook Road
Elmsford NY 10523
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2013-08-28 20,000 $2.73 23,028 No 4 M Direct
Common Stock, Par Value $0.0001 Per Share Acquisiton 2013-08-28 19,687 $6.52 42,715 No 4 M Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2013-08-28 39,687 $11.94 3,028 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.0001 Par Value Employee Stock Option Disposition 2013-08-28 20,000 $0.00 20,000 $2.73
Common Stock, $.0001 Par Value Employee Stock Option Disposition 2013-08-28 19,687 $0.00 19,687 $6.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-04-28 2019-04-28 No 4 M Direct
0 2009-04-29 2018-04-29 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $.0001 Par Value 5,088 Direct
Footnotes
  1. The price reported in column 4 is a weighted average price, rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $11.904 to $11.960 inclusive. The reporting person undertakes to provide to BioScrip, Inc., any security holder of BioScrip, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges forth in this footnote.
  2. Fully vested